The top 100 stock
market authors
selected for publication
market authors
selected for publication
CautiousInvestor
»
Comments
» BBC
You are currently following CautiousInvestor
Stop FollowingYou are no longer following CautiousInvestor
-
1577
)
China: Latest Hotspot for Western Biotech, Pharma Firms [View article]
China is already busy manufacturing generics but there are records of infringements and poor quality control.
Longer-term, though, China is likley to be a key manufacturer of generics which are likley to play an important role in the expansion of US healthcare services, while controlling costs; it's only logical the companies the author mentions take advantage of these opportunity.
The other slant is the health delivery system within China, which is in its infancy but is about to be expanded. Few details have been released, but the Central Party recently announced that by 2020 a system will be in place to provide equitable and cost-effective to health care coverage to the entire population of 1.3 billion.
In my mind, this development offers a very interesting investment theme.